High Tower Advisors, LLC Neogenomics Inc Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 26,747 shares of NEO stock, worth $373,923. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,747

Previous 26,716 0.12%

Holding current value

$373,923

Previous $370,000 6.49%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$13.4 - $17.73 $415 - $549	31 Added 0.12%	26,747 $394,000
Q2 2024 Aug 13, 2024	BUY	$13.01 - $15.77 $347,575 - $421,311	26,716 New	26,716 $370,000
Q2 2022 Aug 10, 2022	SELL	$7.06 - $13.97 $837,944 - $1.66 Million	-118,689 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$12.15 - $35.28 $634,339 - $1.84 Million	-52,209 Reduced 30.55%	118,689 $1.44 Million
Q4 2021 Feb 10, 2022	SELL	$30.49 - $48.49 $53,875 - $85,681	-1,767 Reduced 1.02%	170,898 $5.83 Million
Q3 2021 Nov 12, 2021	SELL	$41.66 - $52.52 $23,996 - $30,251	-576 Reduced 0.33%	172,665 $8.33 Million
Q2 2021 Aug 06, 2021	SELL	$36.62 - $51.69 $55,039 - $77,690	-1,503 Reduced 0.86%	173,241 $7.83 Million
Q1 2021 May 10, 2021	SELL	$41.56 - $59.88 $47,004 - $67,724	-1,131 Reduced 0.64%	174,744 $8.43 Million
Q4 2020 Feb 10, 2021	SELL	$36.08 - $56.47 $186,714 - $292,232	-5,175 Reduced 2.86%	175,875 $9.47 Million
Q3 2020 Nov 13, 2020	SELL	$33.26 - $40.48 $261,157 - $317,848	-7,852 Reduced 4.16%	181,050 $6.68 Million
Q2 2020 Aug 10, 2020	SELL	$24.21 - $31.02 $27,672 - $35,455	-1,143 Reduced 0.6%	188,902 $5.85 Million
Q1 2020 May 21, 2020	SELL	$20.5 - $34.53 $609,280 - $1.03 Million	-29,721 Reduced 13.52%	190,045 $5.25 Million
Q4 2019 Feb 14, 2020	BUY	$18.96 - $29.84 $195,762 - $308,098	10,325 Added 4.93%	219,766 $6.43 Million
Q3 2019 Nov 12, 2019	SELL	$19.12 - $26.24 $845,237 - $1.16 Million	-44,207 Reduced 17.43%	209,441 $4.01 Million
Q2 2019 Aug 13, 2019	BUY	$19.57 - $24.1 $644,361 - $793,516	32,926 Added 14.92%	253,648 $5.56 Million
Q1 2019 May 15, 2019	BUY	$12.14 - $20.46 $16,461 - $27,743	1,356 Added 0.62%	220,722 $4.52 Million
Q4 2018 Feb 14, 2019	SELL	$11.24 - $18.5 $65,945 - $108,539	-5,867 Reduced 2.6%	219,366 $2.77 Million
Q3 2018 Nov 09, 2018	SELL	$12.5 - $15.38 $12,500 - $15,380	-1,000 Reduced 0.44%	225,233 $3.46 Million
Q2 2018 Aug 14, 2018	SELL	$7.99 - $14.05 $181,373 - $318,935	-22,700 Reduced 9.12%	226,233 $2.97 Million
Q1 2018 May 15, 2018	SELL	$7.23 - $8.76 $1,142 - $1,384	-158 Reduced 0.06%	248,933 $2.03 Million
Q4 2017 Feb 14, 2018	SELL	$8.02 - $11.18 $29,866 - $41,634	-3,724 Reduced 1.47%	249,091 $2.21 Million
Q3 2017 Nov 14, 2017	SELL	$9.11 - $11.26 $24,360 - $30,109	-2,674 Reduced 1.05%	252,815 $2.82 Million
Q2 2017 Aug 14, 2017	BUY	N/A	255,489	255,489 $2.29 Million

Others Institutions Holding NEO

# of Institutions

291

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.76B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Neogenomics Inc Transaction History